Opexa Therapeutics (OPXA) to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
11/13/2012 10:29:34 AM
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tcelna™, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil K. Warma, President and Chief Executive Officer, will present at the Lazard Capital Markets 9th Annual Healthcare Conference on Wednesday, November 14, 2012, at 9:00 a.m. EST. The conference will be held at The Pierre Hotel in New York City. A live and archived webcast of the company presentation can be accessed via the Investor Relations section of the Company’s website at www.opexatherapeutics.com.